# Silfurberg

> Silfurberg is a VC fund in Reykjavík backing Biotechnology and Medical. See 3 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Reykjavík, Iceland
- Total investments: 3
- Last investment: Aug 2025
- Lead investor: 33%
- Last updated: Aug 2026
- Website: http://www.silfurberg.is

Silfurberg is an international venture capital firm that invests in early-stage health care, biotech, and other life science companies. The firm follows up its investments as an active participant in the company and aims all the time to add value to its investments whenever possible. Silfurberg was founded in 2002 and is based in Reykjavík,Iceland.

## Contacts

5 contacts available for Silfurberg. Shizune tracks 2 team members at Silfurberg. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/silfurberg?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 2 | 67% |
| Medical | 1 | 33% |
| Health Care | 1 | 33% |
| Life Science | 1 | 33% |
| Pharmaceutical | 1 | 33% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 1 | 33% |
| Series A | 1 | 33% |
| Series C | 1 | 33% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Kristinn Palmason | CFO | 1 | https://shizune.co/investors/profile/kristinn-palmason |
| Friorik Steinn Kristjansson | CEO | 0 | https://shizune.co/investors/profile/friorik-steinn-kristjansson |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Axelyf | Axelyf is a biotechnology company that offers RNA medicines through safer and more effective lipid nanoparticle delivery. | $7.4M | Seed | Aug 07, 2025 |  |
| Oculis | The Oculis drug delivery platform consists of a novel technique to facilitate drug absorption to both anterior and posterior parts of the eye. The advantage is a drug delivery system where diseases of the posterior part of the eye can be treated with a simple topical application. The Oculis drug delivery platform allows diseases such as DME(diabetic macular edema) at the posterior part of the eye to be treated with a non-invasive topical application. Furthermore, the technique has been demonstrated to allow diseases at the anterior part of the eye to be treated with a reduced number of topical applications compared to conventional eye-drops. | $57M | Series C | May 04, 2021 |  |
| Oculis | The Oculis drug delivery platform consists of a novel technique to facilitate drug absorption to both anterior and posterior parts of the eye. The advantage is a drug delivery system where diseases of the posterior part of the eye can be treated with a simple topical application. The Oculis drug delivery platform allows diseases such as DME(diabetic macular edema) at the posterior part of the eye to be treated with a non-invasive topical application. Furthermore, the technique has been demonstrated to allow diseases at the anterior part of the eye to be treated with a reduced number of topical applications compared to conventional eye-drops. |  | Series A | Aug 16, 2016 |  |

3 of 3 investments shown.

## Co-investors
- [Brunnur Ventures](https://shizune.co/investors/profile/venture-capital-fund-brunnur) — VC Fund, 3 deals together
- [Hyfinity Investments](https://shizune.co/investors/profile/hyfinity-investments) — VC Fund, 2 deals together
- [Bay City Capital](https://shizune.co/investors/profile/bay-city-capital) — VC Fund, 1 deal together
- [BVCF](https://shizune.co/investors/profile/bioveda-china-fund) — VC Fund, 1 deal together
- [Earlybird Venture Capital](https://shizune.co/investors/profile/earlybird-venture-capital) — VC Fund, 1 deal together
- [Innovation and Technology Venture Fund](https://shizune.co/investors/profile/innovation-and-technology-venture-fund) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [OrbiMed](https://shizune.co/investors/profile/orbimed-advisors) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [New Business Venture Fund](https://shizune.co/investors/profile/new-business-venture-fund) — VC Fund
- [Frumtak Ventures](https://shizune.co/investors/profile/frumtak) — VC Fund
- [Brunnur Ventures](https://shizune.co/investors/profile/venture-capital-fund-brunnur) — VC Fund

## Featured in investor lists
- [Biotechnology Investors in Iceland](https://shizune.co/investors/biotechnology-investors-iceland)
- [Biotech Investors in Iceland](https://shizune.co/investors/biotech-investors-iceland)
- [Biotech VC Funds in Iceland](https://shizune.co/investors/biotech-vc-funds-iceland)
- [All Investors in Iceland](https://shizune.co/investors/investors-iceland)
- [All VC Funds in Iceland](https://shizune.co/investors/vc-funds-iceland)
- [Medical VC Funds in Iceland](https://shizune.co/investors/medical-vc-funds-iceland)

## FAQ

### What does Silfurberg invest in?

Silfurberg invests primarily in Biotechnology, Medical and Health Care startups, most often at Seed and Series A stage. Most of the 3 investments tracked by Shizune back companies in Iceland. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Silfurberg?

Public channels for Silfurberg include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Silfurberg?

The team at Silfurberg includes Kristinn Palmason (CFO) and Friorik Steinn Kristjansson (CEO). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co